AK-129
- Generic Name
- AK-129
A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Akeso
- Target Recruit Count
- 280
- Registration Number
- NCT06642792
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath